Trial · NCT04965532
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Muscle relaxation recovery index | The first 90 min following intravenous injection of rocuronium | Time interval from 25% recovery to 75% recovery of the first twitch in the TOF stimulation pattern |
| Secondary | Onset time of muscle relaxation | The first 90 min following intravenous injection of rocuronium | Time interval from the completion of intravenous injection of rocuronium to the maximal depression of the first twitch in the TOF stimulation pattern |
| Other | Clinical duration of muscle relaxation | The first 90min following intravenous injection of rocuronium | Time interval from the completion of intravenous injection of rocuronium to 25% recovery of the first twitch in the TOF stimulation pattern |
| Other | TOF ratio | 10min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 10min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 20min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 20min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 30min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 30min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 40min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 40min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 50min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 50min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 60min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 60min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 70min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 70min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 80min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
| Other | T1 amplitude | 80min following intravenous injection of rocuronium | The amplitude of the first twitch to TOF stimulation |
| Other | TOF ratio | 90min following intravenous injection of rocuronium | Dividing the amplitude of the fourth response by the amplitude of the first response |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04965532/registered